More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A FOX FACTORY HOLDING CORP Filed by: Nantahala Capital Management, LLC
-
Form 4 MGP INGREDIENTS INC For: May 14 Filed by: Mingus Lori L.S.
-
Form 424B2 UBS AG
-
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 424B2 UBS AG
-
Form 8-K/A National Healthcare Prop For: May 04
-
Form 144 MONOLITHIC POWER SYSTEMS Filed by: Sciammas Maurice
-
Form 4 AMKOR TECHNOLOGY, INC. For: May 13 Filed by: ALEXANDER DOUGLAS A
-
Form DEF 14A ARES CAPITAL CORP For: Aug 13
-
Form 8-K NETSTREIT Corp. For: May 14
-
Form SCHEDULE 13G Rallybio Corp Filed by: Nantahala Capital Management, LLC
-
Form 13F-HR Xiamen Xinweidachuang For: Mar 31
-
Form SCHEDULE 13G/A RAPT Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 8-K ADVENT TECHNOLOGIES HOLD For: May 14
-
Form 10-Q Primus Acquisition Inc. For: Mar 31
-
Form 8-K READING INTERNATIONAL For: May 15
-
Form 10-Q EQT Infrastructure Co For: Mar 31
-
Form 4 GERDAU S.A. For: May 13 Filed by: Metz Mauricio
-
Form 4 Sotera Health Co For: May 13 Filed by: GTCR FUND XI/C LP
-
Form D/A Kawa Onshore Feeder Fund
-
Form 13F-HR CASTLEARK MANAGEMENT For: Mar 31
-
Form 13F-NT Coatue Innovative Strate For: Mar 31
-
Form NT 10-Q Clean Energy Technologie For: Mar 31
-
Form 144 UNITED PARCEL SERVICE Filed by: Warsh Kevin M
-
Form 13F-HR/A Kalehua Capital Manageme For: Mar 31
-
Form 4 AMKOR TECHNOLOGY, INC. For: May 13 Filed by: McCourt MaryFrances
-
Form FWP BANK OF MONTREAL /CAN/ Filed by: BANK OF MONTREAL /CAN/
-
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: Nantahala Capital Management, LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
Form 10-Q Future FinTech Group For: Mar 31
-
Form 4 H2O AMERICA For: May 13 Filed by: Heather Hunt
-
Form 13F-NT Knighthead GP, LLC For: Mar 31
-
Form FWP BANK5 2026-5YR22 Filed by: WELLS FARGO COMMERCIAL MORTGAGE SECURITIES INC
-
Form SCHEDULE 13G/A Atlas Energy Solutions Filed by: Encompass Capital Advisors LLC
-
Form NT 10-Q IIOT-OXYS, Inc. For: Mar 31
-
Form SCHEDULE 13G/A Dayforce, Inc. Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
-
Form 13F-HR Jessup Wealth Management For: Mar 31
-
Form 10-Q Wetouch Technology Inc. For: Mar 31
-
Form 13F-HR/A CARRONADE CAPITAL MANAGE For: Dec 31
-
Form 13F-HR PAULSON & CO. INC. For: Mar 31
-
Form 8-K Citius Pharmaceuticals, For: May 15
-
Form 4 INSIGHT ENTERPRISES INC For: May 13 Filed by: Armstrong Bruce
-
Form 4 GENTEX CORP For: May 15 Filed by: WALKER BRIAN C
-
Form 8-K RETRACTABLE TECHNOLOGIES For: May 15
-
Form 8-K Bogota Financial Corp. For: May 14
-
Form 13F-HR ABS Direct Equity Fund For: Mar 31
-
Form SCHEDULE 13G/A Sonos Inc Filed by: Coliseum Capital Management, LLC
-
Form 13F-NT SPH Group Holdings LLC For: Mar 31

